Early Removal of the Urinary Catheter After Total or Tumor-Specific Mesorectal Excision for Rectal Cancer Is Safe.
Byung Eun Yoo, Bong Hyeon Kye, Hyung Jin Kim...
https://pubmed.ncbi.nlm.nih.gov/26200683/Actively Recruiting
Led by University of Southern California · Updated on 2026-02-05
176
Participants Needed
2
Research Sites
52 weeks
Total Duration
Researchers are evaluating the optimal duration of urinary catheter use after pelvic colorectal surgery, specifically total mesorectal excision TME. This study aims to compare whether removing the catheter on the first day after surgery is as safe as the current standard of removing it on the third day. The goal is to reduce complications like urinary retention, urinary tract infections, and longer hospital stays, while improving recovery. This is a prospective, randomized, non-inferiority trial conducted by the University of Southern California. Participants undergoing TME will be randomly assigned to two groups one with catheter removal on postoperative day 1 experimental group and the other with removal on day 3 control group. Catheter removal is scheduled at 9 AM on the assigned days. The study involves standard care during and after surgery, including intravenous fluids and monitoring. The main comparison focuses on urinary retention rates, while secondary measures include urinary tract infections and hospital stay length. During the hospital stay, researchers will monitor urinary retention by checking if patients can urinate within 6 hours after catheter removal and using bladder scans if needed. Urinary tract infections will be diagnosed based on symptoms and urine cultures, treated as standard. Data on patient demographics, surgery details, and outcomes will be collected until discharge, which marks the study endpoint. The average hospital stay is about 4 days, and no follow-up is required after discharge.
CONDITIONS
Duration of Urinary Catheterization
S
Sarah Koller, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Southern California
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Catheter removal on day 1 (experimental) | Catheter removal on day 3 (standard care) |
|---|---|---|
| What is it? | Removal of the urinary catheter on the first day after elective mesorectal excision surgery. | Removal of the urinary catheter on the third day after elective mesorectal excision surgery. |
| Role in the trial | Investigational arm to evaluate earlier removal and possible effects on urinary complications and recovery. | Comparator arm representing current standard practice in the study population. |
| Primary use | Aims to reduce risks associated with prolonged catheterization and test if earlier removal is safe and effective. | Commonly used to reduce risk of urinary retention and surgical complications based on established care protocols. |
| How it is performed | Catheter is removed on the first day after surgery followed by monitoring for urinary function and complications. | Catheter is removed on the third day after surgery with continued postoperative monitoring for urinary function and complications. |
| Evidence status | External randomized trials show that early catheter removal is often safe but may increase risk of urinary retention compared with later removal. | Standard day 3 removal is supported by trials showing reduced rates of early urinary retention but may prolong use-related risks (infection, discomfort). |
| Important limitations | Early removal can increase risk of urinary retention, and re-catheterization may be needed. Patient selection is important and protocols may not apply to all surgeries. | Later removal may raise risk of infection and discomfort, and may not shorten recovery compared to earlier removal in some populations. Extended catheterization can itself be problematic. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (perioperative)
Duration - Day of surgery to postoperative day 1 or 3 (depending on group assignment)
Participants undergo total mesorectal excision surgery and receive urinary catheterization during and after surgery as part of standard care.
Hospital stay with daily monitoring
Duration - Up to 3 days post-surgery until catheter removal and monitoring
Participants have their urinary catheter removed either on postoperative day 1 (experimental group) or postoperative day 3 (control group). They are monitored for urinary retention and urinary tract infections.
Hospital stay with daily assessments
Duration - Until hospital discharge (average 4 days post-surgery)
Participants are observed in the hospital until discharge to monitor for urinary retention, urinary tract infections, and length of hospital stay.
Daily hospital visits and assessments until discharge
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Byung Eun Yoo, Bong Hyeon Kye, Hyung Jin Kim...
https://pubmed.ncbi.nlm.nih.gov/26200683/Cindy Kin, Kim F Rhoads, Moe Jalali...
https://pubmed.ncbi.nlm.nih.gov/23652748/Mary R Kwaan, Janet T Lee, David A Rothenberger...
https://pubmed.ncbi.nlm.nih.gov/25751796/Daniel Dindo, Nicolas Demartines, Pierre-Alain Clavien
https://pubmed.ncbi.nlm.nih.gov/15273542/S Benoist, Y Panis, C Denet...
https://pubmed.ncbi.nlm.nih.gov/10026745/Devin N Patel, Seth I Felder, Michael Luu...
https://pubmed.ncbi.nlm.nih.gov/30192326/Jeehyoung Kim, Wonshik Shin
https://pubmed.ncbi.nlm.nih.gov/24605197/University of Southern California
Lead Sponsor